Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 53

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 53
---
 incident to our obligations under the Registration Rights Agreement.

Participation in the PIPE Financing by the Company’s Directors, Executive Officers and 5% Holders

The PIPE Investors include entities that are related to Casey Castelein, M.D., Anupam Dalal, M.D., Behzad Aghazadeh, Ph.D. and Baiteng Zhao, Ph.D., who serve on our board of directors. Bryan Ball, an executive officer for the year ended December 31, 2024, also participated in the PIPE Financing. The following table presents the number of shares of common stock and/or Pre-Funded Warrants, as applicable, purchased and the total purchase price paid by these entities and individuals.

| Investor                           |     | Shares Purchased |           |     | Pre-Funded Warrants Purchased |           |     | Total Purchase Price ($) |           |            |
| Entities affiliated with Avoro (1) |     |                  |         — |     |                               | 8,333,000 |     |                          |           | 19,998,367 |
| Entities affiliated with Acuta (2) |     |                  | 1,561,000 |     |                               |         — |     |                          | 3,746,400 |            |
| KVP Capital, L.P. (3)              |     |                  | 1,666,000 |     |                               |         — |     |                          | 3,998,400 |            |
| Entities affiliated with EcoR1 (4) |     |                  | 2,082,000 |     |                               |         — |     |                          | 4,996,800 |            |
| WZCUBE LLC (5)                     |     |                  | 1,250,000 |     |                               |         — |     |                          | 3,000,000 |            |
| Bryan Ball (6)                     |     |                  |   100,000 |     |                               |         — |     |                          |   240,000 |            |

(1) Dr. Aghazadeh is a member of our board of directors and is a representative of Avoro.

(2) Dr. Dalal is a member of our board of directors and is a representative of Acuta Capital.

(3) Dr. Castelein is a member of our board of directors and is a representative of KVP.

(4) EcoR1 is a beneficial holder